Redeye endorses CLS’ new order of SEK8.1m from ClearPoint Neuro. We also learn that CLS received an order of around SEK2.4m during December 2023. We are positive about today’s news and make some estimate changes and, as a result, reiterate our base case of SEK0.4.
LÄS MER